Skip to main content

Research and statistics

Skip to results
523 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.

  • Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

  • Annual counts and rates of C. difficile infections (CDI) by acute trust and sub-integrated care board location (SICBL) in patients aged 2 years and over.

  • Annual counts and rates of meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

  • Annual counts and rates of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).

  • Annual counts and rates of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).

  • Annual counts and rates of Klebsiella species (Klebsiella spp.) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).

  • Annual counts and rates of Escherichia coli (E. coli) bacteraemia by acute trust and sub-integrated care board location (SICBL).

  • Data on the latest findings relating to antimicrobial resistance in Mycoplasma genitalium from specimens collected in sexual health clinics across England.

  • This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom.

  • This rapid scoping review identifies and summarises existing UK guidance on healthcare provision at events.

  • Annual report on the surveillance of mortality during cold episodes.

  • Reports presenting data for sexually transmitted infections (STIs) in the South West of England.

  • Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination programme for pregnant women.

  • Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination programme for older adults.

  • Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Prevenar 13™ vaccine.

  • Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevenar 13™ in England.

  • UKHSA is working with the NHS to improve identification of sepsis in England. This study will help identify how many adults get sepsis in England and who is most affected.

  • Estimated annual deaths and hospitalisations prevented by routine childhood immunisation in England.

  • Effectiveness of contact tracing strategies for detection of Tuberculosis (TB) in people exposed to a person with active TB in low TB incidence countries.